首页> 外文OA文献 >Persistence and Econ”Mic Impact of Etanercept and Adalimumab Dose Reduction In Rheumatoid Arthritis, Psoriatic Arthropathy and Ankylosing Spondylitis Patients With At Least 1 Year In Clinical Remission: Experience From 2 Spanish Teaching Hospitals During 5 Years of Follow-Up

【2h】

Persistence and Econ”Mic Impact of Etanercept and Adalimumab Dose Reduction In Rheumatoid Arthritis, Psoriatic Arthropathy and Ankylosing Spondylitis Patients With At Least 1 Year In Clinical Remission: Experience From 2 Spanish Teaching Hospitals During 5 Years of Follow-Up

机译：持久性和eCON“麦克风的麦克风和患者的麦克风病毒性关节炎剂量减少，临床缓解至少1年的患者的类风湿性关节炎，银屑病关节病和强直性脊柱炎：在5年后的2个西班牙语教学医院的经验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
B J; R Anton; A Navarro Ruiz; M Castera; R Jd; M A;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Clinical and economic impact of the use of etanercept 25 mg once weekly in rheumatoid arthritis, psoriatic arthropathy and ankylosing spondylitis patients [J] . Borrás-BlascoJ., Gracia-PérezA., Rosique-RoblesJ.D., Expert opinion on biological therapy . 2014,第2期

机译：在风湿性关节炎，银屑病关节炎和强直性脊柱炎患者中，每周一次使用依那西普25 mg的临床和经济影响
2. Comparison of continuation rates with three TNF alpha antagonists (adalimumab, infliximab, etanercept) in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: Retrospective 10-year study [J] . Batteux Benjamin, Devauchelle Agathe, Boyard Pauline Lasselin, Joint, bone, spine : . 2016,第5期

机译：在类风湿性关节炎，强直性脊柱炎和银屑病关节炎中使用三种TNFα拮抗剂（阿达木单抗，英夫利昔单抗，依那西普）的持续率比较：回顾性10年研究
3. CLINICAL AND ECONOMIC IMPACT OF THE USE OF INFLIXIMAB BIOSIMILAR INFLECTRA IN RHEUMATOID ARTHRITIS, PSORIATIC ARTHROPATHY AND ANKYLOSING SPONDYLITIS PATIENTS [J] . Borras Blasco J., Gracia-Perez A., Castera D., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：在风湿性关节炎，银屑病性关节炎和强直性脊柱炎患者中使用英美昔布类真菌感染的临床和经济影响
4. Extended report: Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis juvenile idiopathic arthritis ankylosing spondylitis psoriatic arthritis psoriasis and Crohns disease [O] . Gerd R Burmester, Remo Panaccione, Kenneth B Gordon, -1

机译：扩展报告：阿达木单抗：类风湿性关节炎幼年特发性关节炎强直性脊柱炎银屑病关节炎银屑病和克罗恩病的全球临床试验中23 458名患者的长期安全性
5. 4CPS-111 Clinical and economic impact of infliximab biosimilar Inflectra in rheumatoid arthritis, psoriatic arthropathy and ankylosing spondylitis naïve and switched patients: 5 years of follow-up [O] . J Borras, A Gracia-Pérez, A Valcuende Rosique, 2020

机译：4CPS-111英夫利昔单抗生物纤维腹泻中的临床和经济影响类风湿性关节炎，银屑病关节病和强直性脊柱炎Naïve和切换患者：5年后续行动

Persistence and Econ”Mic Impact of Etanercept and Adalimumab Dose Reduction In Rheumatoid Arthritis, Psoriatic Arthropathy and Ankylosing Spondylitis Patients With At Least 1 Year In Clinical Remission: Experience From 2 Spanish Teaching Hospitals During 5 Years of Follow-Up

著录项

相似文献

相关主题

期刊订阅